Moderna and Pfizer begin late-stage vaccine trials
The studies each aim to enrol 30,000 people and determine whether the vaccines are safe and effective. THE NEW YORK TIMES
The studies each aim to enrol 30,000 people and determine whether the vaccines are safe and effective. THE NEW YORK TIMES